Comprehensive longitudinal analysis of hepatitis C virus (HCV)-specific T cell responses during acute HCV infection in the presence of existing HIV-1 infection

Journal of Viral Hepatitis

Volumn 16, Issue 4, 2009, Pages 239-248

  Van Den Berg, C H S B ^a,b,c   Ruys, T A ^a   Nanlohy, N M ^c   Geerlings, S E ^a   Van Der Meer, J T ^a   Mulder, J W ^d   Lange, J A ^a   Van Baarle, D ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Amsterdam Health Service ^*  (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

Acute viral infection; CD4+ T cells; CD8+ T cells; CTL; HCV; HIV 1; Immunology

Indexed keywords

PEGINTERFERON ALPHA; PEPTIDE; RIBAVIRIN; VIRUS PROTEIN; VIRUS RNA;

ADULT; ARTICLE; ASSAY; BLOOD LEVEL; CASE REPORT; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELLULAR IMMUNITY; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LONGITUDINAL STUDY; MALE; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEXUAL BEHAVIOR; VIRUS GENOME;

ADULT; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HIV-1; HOMOSEXUALITY; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RNA, VIRAL; VIRAL LOAD; VIRAL NONSTRUCTURAL PROTEINS;

EID: 61449255468     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01076.x     Document Type: Article

References (42)

1. Cucchiarini M, Kammer AR, Grabscheid B et al. Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection. Cell Immunol 2000 203 : 111 123.
2. Gruener NH, Tilman Gerlach J, Jung MC et al. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J Infect Dis 2000 181 : 1528 1536.
3. Lancaster T, Sanders E, Christie JM, Brooks C, Green S, Rosenberg WM. Quantitative and functional differences in CD8+ lymphocyte responses in resolved acute and chronic hepatitis C virus infection. J Viral Hepat 2002 9 : 18 28.
4. Lechner F, Wong DK, Dunbar PR et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000 191 : 1499 1512.
5. Freeman AJ, Pan Y, Harvey CE et al. The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection. J Hepatol 2003 38 : 349 356.
6. Nelson DR, Marousis CG, Davis GL et al. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 1997 158 : 1473 1481.
7. Rehermann B, Chang KM, McHutchinson J et al. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 1996 70 : 7092 7102.
8. Diepolder HM, Gerlach JT, Zachoval R et al. Immunodominant CD4+ T cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol 1997 71 : 6011 6019.
9. Diepolder HM, Zachoval R, Hoffmann RM, Jung MC, Gerlach T, Pape GR. The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C. J Mol Med 1996 74 : 583 588.
10. Missale G, Bertoni R, Lamonaca V et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 1996 98 : 706 714.
11. Tilman Gerlach J, Diepolder HM, Jung MC et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T cell response in acute hepatitis C. Gastroenterology 1999 117 : 933 941.
12. Grakoui A, Shoukry NH, Woollard DJ et al. HCV persistence and immune evasion in the absence of memory T cell help. Science 2003 302 : 659 662.
13. Shoukry NH, Grakoui A, Houghton M et al. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J Exp Med 2003 197 : 1645 1655.
14. Mehta SH, Cox A, Hoover DR et al. Protection against persistence of hepatitis C. Lancet 2002 359 : 1478 1483.
15. Thomas DL. Hepatitis C and human immunodeficiency virus infection. Hepatology 2002 36 : S201 S209.
16. Ruys TA, Nanlohy NM, van den Berg CHSB et al. HCV-specific T cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance. J Viral Hepat 2008 15 : 409 420.
17. Piriou ER, van Dort K, Nanlohy NM, van Oers MH, Miedema F, van Baarle D. Novel method for detection of virus-specific CD4+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects. Eur J Immunol 2005 35 : 796 805.
18. Day CL, Lauer GM, Robbins GK et al. Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J Virol 2002 76 : 12584 12595.
19. Reece WH, Pinder M, Gothard PK et al. A CD4(+) T cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. Nat Med 2004 10 : 406 410.
20. Ohno O, Mizokami M, Wu RR et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 1997 35 : 201 207.
21. van Asten L, Verhaest I, Lamzira S et al. Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis. J Infect Dis 2004 189 : 292 302.
22. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001 194 : 1395 1406.
23. van Baarle D, Hovenkamp E, Callan MF et al. Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma. Blood 2001 98 : 146 155.
24. Dutoit V, Ciuffreda D, Comte D, Gonvers JJ, Pantaleo G. Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection. Eur J Immunol 2005 35 : 3493 3504.
25. Kim AY, Lauer GM, Ouchi K et al. The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T cell count in individuals coinfected with HIV-1. Blood 2005 105 : 1170 1178.
26. Gruener NH, Lechner F, Jung MC et al. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol 2001 75 : 5550 5558.
27. Wherry EJ, Ha SJ, Kaech SM et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 2007 27 : 670 684.
28. Alatrakchi NC, Graham S, He Q, Sherman KE, Koziel MJ. CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection. J Infect Dis 2005 191 : 702 709.
29. Tilman Gerlach J, Diepolder HM, Zachoval R et al. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 2003 125 : 80 88.
30. Diepolder HM, Zachoval R, Hoffmann RM et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995 346 : 1006 1007.
31. Rosen HR, Miner C, Sasaki AW et al. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages. Hepatology 2002 35 : 190 198.
32. Schulze zur Wiesch J, Lauer GM, Day CL et al. Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J Immunol 2005 175 : 3603 3613.
33. Eisen-Vandervelde AL, Yao ZQ, Hahn YS. The molecular basis of HCV-mediated immune dysregulation. Clin Immunol 2004 111 : 16 21.
34. Andre P, Perlemuter G, Budkowska A, Brechot C, Lotteau V. Hepatitis C virus particles and lipoprotein metabolism. Semin Liver Dis 2005 25 : 93 104.
35. Eisen-Vandervelde AL, Waggoner SN, Yao ZQ, Cale EM, Hahn CS, Hahn YS. Hepatitis C virus core selectively suppresses interleukin-12 synthesis in human macrophages by interfering with AP-1 activation. J Biol Chem 2004 279 : 43479 43486.
36. Rehermann B, Chang KM, McHutchison JG, Kokka R, Houghton M, Chisari FV. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 1996 98 : 1432 1440.
37. Jaeckel E, Cornberg M, Wedemeyer H et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001 345 : 1452 1457.
38. Vogel M, Bieniek B, Jessen H et al. Treatment of acute hepatitis C infection in HIV-infected patients: a retrospective analysis of eleven cases. J Viral Hepat 2005 12 : 207 211.
39. Serpaggi J, Chaix ML, Batisse D et al. Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy. AIDS 2006 20 : 233 240.
40. Lauer GM, Lucas M, Timm J et al. Full-breadth analysis of CD8+ T cell responses in acute hepatitis C virus infection and early therapy. J Virol 2005 79 : 12979 12988.
41. Danta M, Brown D, Bhagani S et al. Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS 2007 21 : 983 991.
42. van de Laar TW, van der Bij AK, Prins M et al. Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. J Infect Dis 2007 196 : 230 238.